Czech Republic: Market for Other Medicaments For Therapeutic Or Prophylactic Uses 2024

Market Size for Other Medicaments For Therapeutic Or Prophylactic Uses in the Czech Republic

The Czech market for other medicaments for therapeutic or prophylactic uses dropped notably to $X in 2022, falling by X% against the previous year. In general, the total consumption indicated a prominent increase from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption decreased by X% against 2019 indices. Over the period under review, the market hit record highs at $X in 2019; however, from 2020 to 2022, consumption remained at a lower figure.

Production of Other Medicaments For Therapeutic Or Prophylactic Uses in the Czech Republic

In value terms, production of other medicaments for therapeutic or prophylactic uses reduced to $X in 2022 estimated in export price. Over the period under review, production, however, saw a buoyant expansion. The growth pace was the most rapid in 2021 when the production volume increased by X%. As a result, production reached the peak level of $X, and then fell in the following year.

Exports of Other Medicaments For Therapeutic Or Prophylactic Uses

Exports from the Czech Republic

In 2022, overseas shipments of other medicaments for therapeutic or prophylactic uses increased by X% to X tons, rising for the second consecutive year after three years of decline. Overall, exports enjoyed significant growth. The growth pace was the most rapid in 2013 when exports increased by X%. Over the period under review, the exports of reached the peak figure in 2022 and are expected to retain growth in the immediate term.

In value terms, exports of other medicaments for therapeutic or prophylactic uses rose to $X in 2022. In general, exports saw a strong increase. The pace of growth was the most pronounced in 2013 with an increase of X%. Over the period under review, the exports of attained the peak figure at $X in 2019; however, from 2020 to 2022, the exports failed to regain momentum.

Exports by Country

Slovakia (X tons) was the main destination for exports of other medicaments for therapeutic or prophylactic uses from the Czech Republic, with a X% share of total exports. Moreover, exports of other medicaments for therapeutic or prophylactic uses to Slovakia exceeded the volume sent to the second major destination, Denmark (X tons), more than tenfold. Germany (X tons) ranked third in terms of total exports with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of volume to Slovakia amounted to X%. Exports to the other major destinations recorded the following average annual rates of exports growth: Denmark (X% per year) and Germany (X% per year).

In value terms, the largest markets for other medicaments for therapeutic or prophylactic uses exported from the Czech Republic were Slovakia ($X), Germany ($X) and Denmark ($X), together comprising X% of total exports.

Among the main countries of destination, Slovakia, with a CAGR of X%, recorded the highest rates of growth with regard to the value of exports, over the period under review, while shipments for the other leaders experienced more modest paces of growth.

Export Prices by Country

In 2022, the average export price for other medicaments for therapeutic or prophylactic uses amounted to $X per ton, shrinking by X% against the previous year. Over the period under review, the export price recorded a deep reduction. The pace of growth was the most pronounced in 2018 when the average export price increased by X%. The export price peaked at $X per ton in 2012; however, from 2013 to 2022, the export prices remained at a lower figure.

Prices varied noticeably by country of destination: amid the top suppliers, the country with the highest price was Germany ($X,320 per ton), while the average price for exports to Slovakia ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to Germany (X%), while the prices for the other major destinations experienced mixed trend patterns.

Imports of Other Medicaments For Therapeutic Or Prophylactic Uses

Imports into the Czech Republic

In 2022, after two years of growth, there was significant decline in purchases abroad of other medicaments for therapeutic or prophylactic uses, when their volume decreased by X% to X tons. Overall, imports saw a relatively flat trend pattern. The most prominent rate of growth was recorded in 2021 with an increase of X% against the previous year. As a result, imports reached the peak of X tons, and then contracted remarkably in the following year.

In value terms, imports of other medicaments for therapeutic or prophylactic uses contracted significantly to $X in 2022. Over the period under review, imports, however, continue to indicate a strong expansion. The most prominent rate of growth was recorded in 2021 when imports increased by X%. As a result, imports reached the peak of $X, and then contracted remarkably in the following year.

Imports by Country

In 2022, Ireland (X tons) constituted the largest supplier of other medicaments for therapeutic or prophylactic uses to the Czech Republic, with a X% share of total imports. Moreover, imports of other medicaments for therapeutic or prophylactic uses from Ireland exceeded the figures recorded by the second-largest supplier, Spain (X tons), fivefold. The third position in this ranking was taken by Switzerland (X tons), with a X% share.

From 2012 to 2022, the average annual growth rate of volume from Ireland totaled X%. The remaining supplying countries recorded the following average annual rates of imports growth: Spain (X% per year) and Switzerland (X% per year).

In value terms, Ireland ($X), Slovakia ($X) and Poland ($X) were the largest other medicaments for therapeutic or prophylactic uses suppliers to the Czech Republic, with a combined X% share of total imports. Switzerland, Greece, Spain, France, Israel, Belgium, the United States and the UK lagged somewhat behind, together comprising a further X%.

Israel, with a CAGR of X%, recorded the highest growth rate of the value of imports, in terms of the main suppliers over the period under review, while purchases for the other leaders experienced more modest paces of growth.

Import Prices by Country

The average import price for other medicaments for therapeutic or prophylactic uses stood at $X per ton in 2022, surging by X% against the previous year. Over the period under review, the import price showed resilient growth. As a result, import price attained the peak level and is likely to continue growth in the immediate term.

There were significant differences in the average prices amongst the major supplying countries. In 2022, amid the top importers, the country with the highest price was Slovakia ($X,357 per ton), while the price for the United States ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by South Africa (X.9%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :